Micar Innovation Business Model an biopharmaceutical company profitable and firmly anchored in its community

Micar Innovation business model and organization are predicated on the co-existence of four business streams /Licensing of our own Pipeline, Parthership, Project: 22 new treatments of rare and ultra rare diseases, Factory for Drug Discovery of novel compounds for the treatment of diversity diseases/ that respectively provide short, medium and long-term revenue streams.

Besides our services we have also own own drug discovery pipeline, which is in a preclinical stage

Capital structure

Founded in 2016, Micar Innovation is built on a balanced business model. Micar Innovation capital is in the hands of its top management. Thus, the interests of its management remain perfectly aligned.

We're aiming for 50 new treatments by 2030

Look at the data with us

Micar Innovation (Micar21) - Your Factory for Drug Design and Discovery

Try our Drug Discovery Services

Please see our Drug Discovery Services & Prices